Peripheral arterial disease: Predictors and treatment, based on the two-year data of the INVADE study;Periphere arterielle verschlusskrankheit: Prädiktoren und behandlungsintensität - 2-jahres daten des populationsbasierten INVADE-projekts

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 10, 2008, Pages 455-459

  Sander, Kerstin ^a,c,d   Bickel, H ^a   Schulze Horn, C ^a   Huntgeburth, U ^b   Poppert, H ^a   Sander, D ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INVADE Study Group

^c Neurologische Klinik   (Germany)

^d Neurologische Klinik Medical   (Austria)

Author keywords

Ankle brachial index (ABI); Epidemiology; Peripheral arterial disease; Prevention; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; FISHER EXACT TEST; HUMAN; MULTIPLE REGRESSION; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; STUDENT T TEST; TREATMENT INDICATION; AGE; AGED; COHORT ANALYSIS; FEMALE; GERMANY; MALE; STATISTICAL MODEL;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 40049101010     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1046731     Document Type: Article

References (20)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 Suppl 1: S43-8
2. Abdellaoui A, Al-Khaffaf H. C-Reactive Protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg 2007; 34: 18-22
3. Catalano M, Born G, Peto R. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 2007; 261: 276-84
4. Diehm C, Lange S, Darius H et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 27 (14): 1743-49
5. Diehm C, Schuster A, Allenberg JR et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105
6. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2001; 31: S1-S296
7. Heald CL, Fowkes FC, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis 2006; 189: 61-69
8. Musicant SE, Taylor LMJr, Peters D et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg 2006; 43: 772-80
9. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 Suppl 1: S1-75
10. Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26: 81-157
11. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2007; 55: 583-89
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97 (5): 425-28
13. Sander D, Schulze-Horn C, Bickel H et al. Combined effects of hemoglobin A1c and c-reactive Protein on the progression of subclinical carotid atherosclerosis: The INVADE Study. Stroke 2006; 37: 351-57
14. Sander K, Schulze Horn C, Briesenick C, Sander D. Signifikante Reduktion vaskulärer Risikofaktoren im Rahmen des populationsbasierten Interventionsprojektes INVADE - Eine 2-Jahres-Verlaufsuntersuchung. Dtsch Med Wochenschr 2006; 131: 1853-1859
15. Scherpinski U, Bickel H, Gnahn H, Forstl H, Conrad B, Sander D. Interventionsprojekt zu zerebrovaskulären Erkrankungen und Demenz im Landkreis Ebersberg (INVADE). Rationale und Projektdesign. Nervenarzt 2002; 73: 1199-204
16. Schulze Horn C, Sander K, Ilg R, Bickel H, Briesenick C, Sander D. Modifikation von vaskulären Risikofaktoren durch hausärztliche Intervention: Ergebnisse des Projekts INVADE. Nervenarzt, 2007; in press
17. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-43
18. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 2001; 32: 1721-24
19. Tzoulaki I, Murray GD, Price JF et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 2006; 163: 334-41
20. Weatherley BD, Nelson JJ, Heiss G et al. The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001. BMC Cardiovasc Disord 2007; 7: 3